Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ:SNOA)

1.375 -0.005 (-0.36%)

Streaming Delayed Price Updated: 11:45 AM EDT, Aug 27, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	17,329
Open	1.400
Bid (Size)	1.350 (900)
Ask (Size)	1.400 (12,800)
Prev. Close	1.380
Today's Range	1.360 - 1.400
52wk Range	0.8501 - 4.871
Shares Outstanding	1,730,613
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

August 06, 2026

From Sonoma Pharmaceuticals, Inc.

Via ACCESS Newswire

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

June 30, 2026

From Sonoma Pharmaceuticals, Inc.

Via ACCESS Newswire

Performance

YTD	-62.2%	-62.2%
1 Month	+19.6%	+19.6%
3 Month	+27.3%	+27.3%
6 Month	-52.0%	-52.0%
1 Year	-71.5%	-71.5%

More News

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

June 16, 2026

From Sonoma Pharmaceuticals, Inc.

Via ACCESS Newswire

Unusual volume stocks are being observed in Tuesday's session. ↗

April 28, 2026

Via Chartmill

Unusual volume stocks in Monday's session ↗

April 27, 2026

Via Chartmill

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

April 24, 2026

Via ACCESS Newswire

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

March 24, 2026

Via ACCESS Newswire

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

March 18, 2026

Via ACCESS Newswire

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

February 10, 2026

Via ACCESS Newswire

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

November 13, 2025

Via ACCESS Newswire

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

November 06, 2025

Via ACCESS Newswire

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

November 04, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 14, 2025

Via Benzinga

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

October 14, 2025

Via ACCESS Newswire

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

October 07, 2025

Via ACCESS Newswire

Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

September 25, 2025

Via ACCESS Newswire

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

August 26, 2025

Via ACCESS Newswire

5 Healthcare Stocks On Fire This Week ↗

August 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 15, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

August 14, 2025

Via Chartmill

Which stocks are most active on Thursday? ↗

August 14, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 14, 2025

Via Benzinga

Thursday's session: top gainers and losers ↗

August 14, 2025

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

August 14, 2025

Via Chartmill

Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results ↗

August 14, 2025

Via Benzinga

Frequently Asked Questions

Is Sonoma Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Sonoma Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Sonoma Pharmaceuticals, Inc. - Common Stock trade on?

Sonoma Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock is SNOA on the Nasdaq Stock Market

What is the current price of Sonoma Pharmaceuticals, Inc. - Common Stock?

The current price of Sonoma Pharmaceuticals, Inc. - Common Stock is 1.375

When was Sonoma Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Sonoma Pharmaceuticals, Inc. - Common Stock was at 08/27/26 11:45 AM ET

What is the market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock is 2.38M

How many shares of Sonoma Pharmaceuticals, Inc. - Common Stock are outstanding?

Sonoma Pharmaceuticals, Inc. - Common Stock has 2M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.